While Progyny Inc has overperformed by 3.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PGNY fell by -46.78%, with highs and lows ranging from $42.08 to $13.39, whereas the simple moving average fell by -9.68% in the last 200 days.
On December 02, 2024, JP Morgan Downgraded Progyny Inc (NASDAQ: PGNY) to Neutral. A report published by Truist on November 13, 2024, Downgraded its rating to ‘Hold’ for PGNY. Leerink Partners August 07, 2024d the rating to Market Perform on August 07, 2024, and set its price target from $31 to $25. Canaccord Genuity August 07, 2024d its ‘Buy’ rating to ‘Hold’ for PGNY, as published in its report on August 07, 2024. JMP Securities also rated the stock as ‘Mkt Outperform’.
Analysis of Progyny Inc (PGNY)
Further, the quarter-over-quarter increase in sales is 2.04%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Progyny Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of 12.05% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.62, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and PGNY is recording an average volume of 1.79M. On a monthly basis, the volatility of the stock is set at 4.72%, whereas on a weekly basis, it is put at 6.01%, with a gain of 18.71% over the past seven days. Furthermore, long-term investors anticipate a median target price of $19.86, showing decline from the present price of $20.75, which can serve as yet another indication of whether PGNY is worth investing in or should be passed over.
How Do You Analyze Progyny Inc Shares?
A leading company in the Health Information Services sector, Progyny Inc (PGNY) is based in the USA. When comparing Progyny Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 35.75, there is a growth in quarterly earnings of -29.51%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.43%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 91.65% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PGNY shares are owned by institutional investors to the tune of 91.65% at present.
